Sensitivity, specificity, PPV, and NPV of 14-Gene-Panel, prostate-specific antigen (PSA) and Gleason score for diagnosis of higher-risk and lower-risk prostate cancer (PCa) in a prospective PCa urine cohort. This evidence concerns the gene KLK3 and prostate carcinoma.